<DOC>
	<DOCNO>NCT00576511</DOCNO>
	<brief_summary>The purpose study determine whether prucalopride safe effective patient severe chronic constipation .</brief_summary>
	<brief_title>Effect Prucalopride Patients With Severe Chronic Idiopathic Constipation</brief_title>
	<detailed_description>This phase II trial parallel-group design , consist run-in phase ( phase I ) , follow placebo control double-blind phase ( phase 2 ) . Patients receive either R093877 4 mg placebo o.d . period 4 week . Phase 1 run-in period 4 week duration , bowel habit document existence constipation determine . If definition constipation meet 4 week run-in period , double-blind treatment start . Phase 2 double-blind , randomize , placebo-controlled phase , patient treat 4 week either 4 mg R093877 placebo give o.d . ( two capsule 2 mg take breakfast ) .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>Patients eligible inclusion age 1875 year history constipation , define occurrence 2 follow criterion previous 6 month : 2 spontaneous ( i.e . induced laxative within 24 hour ) bowel movement per week ; 25 % stool lumpy and/or hard ; sensation incomplete evacuation follow 25 % stool ; strain defaecation 25 % time . All patient screen study dependent osmotic laxative ( macrogol , milk magnesia , lactulose ) , paraffin oil , glycerol stimulant laxative ( antranoids , diphenylmethanes ) give orally rectally . The osmotic laxative take daily base stimulant laxatives restrict 2 , eventually 3 intake per week . And although laxative , combine promoted defaecation majority patient , regimen provide relief constipation symptom none patient . Furthermore , many patient report effect laxative decline time , intake even stimulant laxative consistently follow rectal evacuation intake even stimulant laxative consistently follow rectal evacuation dose frequency intake laxative limit intolerable side effect include vomit abdominal cramp . Eligible patient also require constipation cause disability , patient 's occupational , social recreational activity govern constipation effort attain relief , poor result laxative treatment diet counseling determine physician interview . Patients also normal electromyographic inhibition pattern external anal sphincter straining ( assessed start treatment phase ) absence organic abnormality colon ( assessed barium enema total colonoscopy ) . Druginduced constipation Secondary cause constipation Known suspect organic large bowel disorder Congenital acquire megacolon/megarectum History previous abdominal surgery Evidence nonrelaxing pelvic floor main cause constipation Active proctological condition Impaired renal function clinically significant abnormality blood chemistry , hematology , urinalysis ECG . Patients pregnant , breast feeding , use acceptable method birth control know illness condition might interfere adequate assessment study drug also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Constipation</keyword>
	<keyword>Prucalopride</keyword>
	<keyword>Colonic Transit Time</keyword>
</DOC>